Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
HealOS
AddedMay 12, 2026
UpdatedMay 30, 2026
HealOS

HealOS

Seed

HealOS delivers six AI agents that automate administrative workflows for medical practices.

HQ
Brooklyn, NY, US
Founded
2023
Overview
Analysis
Compare
Fundraising
Employees
News
Website

HealOS is a Y Combinator-backed healthcare automation platform that deploys six specialized AI agents for medical practices.

The platform handles clinical documentation, patient communications, insurance verification, prior authorizations, fax processing, and revenue cycle management with 98% accuracy and HIPAA/SOC 2 Type II compliance.

HealOS - Similar Companies

Sohar Health logo

Sohar Health

soharhealth.com

Ascertain logo

Ascertain

ascertain.com

Lassie logo

Lassie

lassie.ai

Health Harbor logo

Health Harbor

healthharbor.co

Shasta Health logo

Shasta Health

shasta.health

Sopris Health logo

Sopris Health

soprishealth.com

HealerPlus logo

HealerPlus

healerplus.com

Prosper AI logo

Prosper AI

getprosper.ai

TriFetch logo

TriFetch

trifetch.ai

Mykare.ai logo

Mykare.ai

mykare.ai

Decoda Health logo

Decoda Health

decodahealth.com

Co:Helm logo

Co:Helm

co-helm.com

Nimblr.ai logo

Nimblr.ai

nimblr.ai

Substrate logo

Substrate

substrate.cc

Aegis logo

Aegis

aegishealth.us

HealOS - Quick Facts

Who are HealOS' competitors?

Companies similar to HealOS include Sohar Health, Ascertain, Lassie and Health Harbor.

When was HealOS founded?

HealOS was founded in 2023.

Where is HealOS' headquarters located?

HealOS' headquarters is located in Brooklyn, NY, US.

When was HealOS' last funding round?

HealOS' most recent funding round was for $1.2M (USD) in March 2025.

How much has HealOS raised to-date?

As of Mar 23, 2025, HealOS has raised a total of $1.2M (USD).

HealOS - Classification

Industry
  • Healthcare IT
Ownership
  • Private
Technology
  • AI
  • Automation
  • EHR Integration
  • Healthcare IT
  • NLP
  • OCR
Geographic Exposure
  • Americas United States
Model
  • B2B SaaS
Revenue
  • Subscription
Customer
  • Healthcare Providers